Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]
Your healthcare team can help you distinguish between the two and adjust your doses accordingly
Benefits of SGLT2 inhibitors beyond glycemic control - a focus on metabolic, cardiovascular and renal outcomes
With real-time online consultations , you can begin your transformation from the comfort and privacy of your homeno waiting rooms, no judgment
Predicting Side Effects: We found genetic variants in both the GLP1R and GIPR genes linked to a higher likelihood of experiencing nausea and vomiting
It helps eliminate toxins, neutralize free radicals, and reduce oxidative stress to support overall health